Trials / Completed
CompletedNCT03097783
Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Efficacy and Safety of Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 169 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, multi-center, evaluator-blinded, no-treatment controlled study to evaluate the efficacy and safety of Restylane Perlane Lidocaine for correction of Midface Volume Deficit and/or Midface Contour Deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane Perlane Lidocaine | Intradermal injection |
Timeline
- Start date
- 2017-04-26
- Primary completion
- 2018-03-23
- Completion
- 2018-09-14
- First posted
- 2017-03-31
- Last updated
- 2023-11-03
- Results posted
- 2021-07-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03097783. Inclusion in this directory is not an endorsement.